These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 15120609

  • 1. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells.
    He GA, Luo JX, Zhang TY, Hu ZS, Wang FY.
    Biochem Biophys Res Commun; 2004 May 28; 318(2):354-60. PubMed ID: 15120609
    [Abstract] [Full Text] [Related]

  • 2. Canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth.
    He GA, Luo JX, Zhang TY, Wang FY, Li RF.
    Biochem Biophys Res Commun; 2003 Dec 19; 312(3):801-5. PubMed ID: 14680836
    [Abstract] [Full Text] [Related]

  • 3. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y, Zhang ZY.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2324-30. PubMed ID: 19080341
    [Abstract] [Full Text] [Related]

  • 4. Expression, purification, and bioactivity of human tumstatin from Escherichia coli.
    Gu Q, Zhang T, Luo J, Wang F.
    Protein Expr Purif; 2006 Jun 20; 47(2):461-6. PubMed ID: 16503164
    [Abstract] [Full Text] [Related]

  • 5. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
    Morbidelli L, Donnini S, Chillemi F, Giachetti A, Ziche M.
    Clin Cancer Res; 2003 Nov 01; 9(14):5358-69. PubMed ID: 14614021
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of antiangiogenic effects of human canstatin with a hypoxia-regulated transgene vector in lung cancer model.
    Li YY, Qian GS, Huang GJ, Chen F, Qian P, Yu SC, Wang CZ, Li Q, Wang JC, Wu GM.
    Cancer J; 2006 Nov 01; 12(2):136-46. PubMed ID: 16630405
    [Abstract] [Full Text] [Related]

  • 7. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
    Hagedorn M, Zilberberg L, Wilting J, Canron X, Carrabba G, Giussani C, Pluderi M, Bello L, Bikfalvi A.
    Cancer Res; 2002 Dec 01; 62(23):6884-90. PubMed ID: 12460903
    [Abstract] [Full Text] [Related]

  • 8. Recombinant non-collagenous domain of alpha2(IV) collagen causes involution of choroidal neovascularization by inducing apoptosis.
    Lima E Silva R, Kachi S, Akiyama H, Shen J, Aslam S, Yuan Gong Y, Khu NH, Hatara MC, Boutaud A, Peterson R, Campochiaro PA.
    J Cell Physiol; 2006 Jul 01; 208(1):161-6. PubMed ID: 16557520
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4.
    Ito Y, Oike Y, Yasunaga K, Hamada K, Miyata K, Matsumoto S, Sugano S, Tanihara H, Masuho Y, Suda T.
    Cancer Res; 2003 Oct 15; 63(20):6651-7. PubMed ID: 14583458
    [Abstract] [Full Text] [Related]

  • 10. The COOH-terminal globular domain of fibrinogen gamma chain suppresses angiogenesis and tumor growth.
    Akakura N, Hoogland C, Takada YK, Saegusa J, Ye X, Liu FT, Cheung AT, Takada Y.
    Cancer Res; 2006 Oct 01; 66(19):9691-7. PubMed ID: 17018627
    [Abstract] [Full Text] [Related]

  • 11. Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis.
    Berger AC, Alexander HR, Tang G, Wu PS, Hewitt SM, Turner E, Kruger E, Figg WD, Grove A, Kohn E, Stern D, Libutti SK.
    Microvasc Res; 2000 Jul 01; 60(1):70-80. PubMed ID: 10873516
    [Abstract] [Full Text] [Related]

  • 12. [Inhibitory effect of recombinant anti-angiogenic peptide of tumstatin on growth and metastasis of human ovarian cancer transplanted in nude mice].
    Zhang GM, Sui LH, Jia T, Zhao YZ, Fu SB, Liu XH, Yu Y.
    Zhonghua Zhong Liu Za Zhi; 2008 Mar 01; 30(3):170-3. PubMed ID: 18756929
    [Abstract] [Full Text] [Related]

  • 13. Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.
    Hwang-Bo J, Yoo KH, Park JH, Jeong HS, Chung IS.
    Int J Cancer; 2012 Jul 15; 131(2):298-309. PubMed ID: 21823121
    [Abstract] [Full Text] [Related]

  • 14. The anti-angiogenic activity of human endostatin inhibits bladder cancer growth and its mechanism.
    Du Z, Hou S.
    J Urol; 2003 Nov 15; 170(5):2000-3. PubMed ID: 14532841
    [Abstract] [Full Text] [Related]

  • 15. Recombinant human interleukin-24 suppresses gastric carcinoma cell growth in vitro and in vivo.
    Yan S, Zhang H, Xie Y, Sheng W, Xiang J, Ye Z, Chen W, Yang J.
    Cancer Invest; 2010 Jan 15; 28(1):85-93. PubMed ID: 19916746
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F, Engst S, Yamaguchi K, Yu P, Won KA, Mock L, Lou T, Tan J, Li C, Tam D, Lougheed J, Yakes FM, Bentzien F, Xu W, Zaks T, Wooster R, Greshock J, Joly AH.
    Cancer Res; 2009 Oct 15; 69(20):8009-16. PubMed ID: 19808973
    [Abstract] [Full Text] [Related]

  • 17. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A, Vassy R, Martin A, Lecouvey M, Di Benedetto M, Crépin M, Perret GY.
    Life Sci; 2006 Nov 17; 79(25):2370-81. PubMed ID: 16959272
    [Abstract] [Full Text] [Related]

  • 18. Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain.
    Juarez JC, Guan X, Shipulina NV, Plunkett ML, Parry GC, Shaw DE, Zhang JC, Rabbani SA, McCrae KR, Mazar AP, Morgan WT, Doñate F.
    Cancer Res; 2002 Sep 15; 62(18):5344-50. PubMed ID: 12235005
    [Abstract] [Full Text] [Related]

  • 19. Recombinant mouse canstatin inhibits chicken embryo chorioallantoic membrane angiogenesis and endothelial cell proliferation.
    Hou WH, Wang TY, Yuan BM, Chai YR, Jia YL, Tian F, Wang JM, Xue LX.
    Acta Biochim Biophys Sin (Shanghai); 2004 Dec 15; 36(12):845-50. PubMed ID: 15592653
    [Abstract] [Full Text] [Related]

  • 20. N-/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent.
    Cho H, Kim WJ, Lee YM, Kim YM, Kwon YG, Park YS, Choi EY, Kim KW.
    Oncol Rep; 2004 Jan 15; 11(1):191-5. PubMed ID: 14654925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.